KMO and Huntington disease: The ablation of kynurenine-3-monooxygenase (KMO), an enzyme responsible for increasing the levels of tryptophan neurotoxic metabolites, increases the level of KYNA in several regions of the brain and peripheral organs of R6/2 HD mouse models [137].